Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBYI | AZN | AMGN | GILD | BMY |
| Company | Puma Biotechnology | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 6.67 | 202.52 | 366.66 | 153.42 | 60.00 |
| High | 6.77 | 205.86 | 370.52 | 155.73 | 60.93 |
| Low | 6.48 | 202.10 | 365.06 | 150.82 | 59.25 |
| Latest | 6.74 | 205.53 | 369.92 | 152.86 | 60.25 |
| Change | +0.10 | +0.77 | +3.34 | -2.94 | +0.32 |
| % Change | +1.51% | +0.38% | +0.91% | -1.89% | +0.53% |
| Volume | 192,022 | 1,942,671 | 1,097,831 | 5,794,640 | 7,674,805 |
| 20-Day Average Volume | 428,759 | 4,579,482 | 3,156,244 | 8,702,924 | 13,403,604 |
| Previous Close | 6.64 | 204.76 | 366.58 | 155.80 | 59.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 6.67 | 188.78 | 351.63 | 140.42 | 56.87 |
| 20-Day Raw Stochastic | 47.32% | 98.83% | 74.63% | 87.83% | 83.13% |
| 20-Day Relative Strength | 57.13 | 65.42 | 61.48 | 68.68 | 65.98 |
| Weighted Alpha | +84.07 | +48.81 | +33.65 | +56.72 | +24.00 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 48% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.66% since 02/05/26 | +9.65% since 02/05/26 | +0.33% since 02/05/26 | +2.34% since 02/05/26 | +1.84% since 02/05/26 |
| Low | 6.37 on 02/11/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 7.05 on 02/06/26 | 205.54 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +7.40% since 01/12/26 | +9.59% since 01/12/26 | +13.36% since 01/12/26 | +24.69% since 01/12/26 | +8.69% since 01/12/26 |
| Low | 6.11 on 01/13/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 53.54 on 01/21/26 |
| High | 7.28 on 02/05/26 | 205.54 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +35.17% since 11/12/25 | +17.03% since 11/12/25 | +9.74% since 11/12/25 | +23.88% since 11/12/25 | +23.50% since 11/12/25 |
| Low | 4.76 on 11/14/25 | 175.24 on 11/13/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 7.28 on 02/05/26 | 205.54 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +38.50% since 08/12/25 | +36.20% since 08/12/25 | +29.49% since 08/12/25 | +27.37% since 08/12/25 | +30.21% since 08/12/25 |
| Low | 4.30 on 09/17/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 7.28 on 02/05/26 | 205.54 on 02/12/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 334,596 | 317,563,904 | 197,396,352 | 193,297,952 | 122,002,680 |
| Shares Outstanding, K | 50,391 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 230,470,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | 30,280,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 54,480,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 8,840,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 1.22 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.21 on 11/06/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 8.93 | 23.88 | 16.69 | 18.07 | 9.90 |